Ymke M. van der Geld

771 total citations
14 papers, 608 citations indexed

About

Ymke M. van der Geld is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Genetics. According to data from OpenAlex, Ymke M. van der Geld has authored 14 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 4 papers in Genetics. Recurrent topics in Ymke M. van der Geld's work include Vasculitis and related conditions (10 papers), Sarcoidosis and Beryllium Toxicity Research (5 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). Ymke M. van der Geld is often cited by papers focused on Vasculitis and related conditions (10 papers), Sarcoidosis and Beryllium Toxicity Research (5 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). Ymke M. van der Geld collaborates with scholars based in Netherlands, United States and Sweden. Ymke M. van der Geld's co-authors include Cees G. M. Kallenberg, Coen A. Stegeman, Wayel H. Abdulahad, Pieter C. Limburg, Berber Doornbos‐van der Meer, Wim Timens, Dirkje S. Postma, Jacobien A. Noordhoek, P. C. Limburg and André Zandvoort and has published in prestigious journals such as Kidney International, Annals of the Rheumatic Diseases and European Respiratory Journal.

In The Last Decade

Ymke M. van der Geld

14 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ymke M. van der Geld Netherlands 11 470 250 138 124 104 14 608
Margaret A. Viss United States 10 540 1.1× 144 0.6× 175 1.3× 113 0.9× 95 0.9× 11 650
Laura S. van Dam Netherlands 12 250 0.5× 302 1.2× 138 1.0× 42 0.3× 130 1.3× 18 558
Lavanya Kamesh United Kingdom 8 176 0.4× 200 0.8× 128 0.9× 32 0.3× 165 1.6× 12 578
Elisabeth A. Berg United States 7 474 1.0× 289 1.2× 187 1.4× 107 0.9× 120 1.2× 9 604
William F. Jiemy Netherlands 11 218 0.5× 108 0.4× 134 1.0× 62 0.5× 55 0.5× 26 336
Ana C. Glembotsky Argentina 17 101 0.2× 118 0.5× 100 0.7× 42 0.3× 164 1.6× 31 731
Ayumi Okuyama Japan 11 113 0.2× 91 0.4× 206 1.5× 22 0.2× 97 0.9× 23 445
Charles J. Pruchno United States 11 84 0.2× 202 0.8× 74 0.5× 106 0.9× 110 1.1× 12 525
G Schäffner Germany 5 130 0.3× 88 0.4× 40 0.3× 22 0.2× 170 1.6× 10 566
Alicia Humbría Spain 8 50 0.1× 183 0.7× 136 1.0× 172 1.4× 56 0.5× 11 430

Countries citing papers authored by Ymke M. van der Geld

Since Specialization
Citations

This map shows the geographic impact of Ymke M. van der Geld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ymke M. van der Geld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ymke M. van der Geld more than expected).

Fields of papers citing papers by Ymke M. van der Geld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ymke M. van der Geld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ymke M. van der Geld. The network helps show where Ymke M. van der Geld may publish in the future.

Co-authorship network of co-authors of Ymke M. van der Geld

This figure shows the co-authorship network connecting the top 25 collaborators of Ymke M. van der Geld. A scholar is included among the top collaborators of Ymke M. van der Geld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ymke M. van der Geld. Ymke M. van der Geld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Geld, Ymke M. van der, Thomas Hellmark, Daina Selga, et al.. (2007). Rats and mice immunised with chimeric human/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes. Annals of the Rheumatic Diseases. 66(12). 1679–1682. 53 indexed citations
2.
Abdulahad, Wayel H., Coen A. Stegeman, Ymke M. van der Geld, et al.. (2007). Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission. Arthritis & Rheumatism. 56(6). 2080–2091. 139 indexed citations
3.
Zandvoort, André, Dirkje S. Postma, Marnix R. Jonker, et al.. (2006). Altered expression of the Smad signalling pathway: implications for COPD pathogenesis. European Respiratory Journal. 28(3). 533–541. 67 indexed citations
4.
Abdulahad, Wayel H., Ymke M. van der Geld, Coen A. Stegeman, & Cees G. M. Kallenberg. (2006). Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis. Kidney International. 70(5). 938–947. 117 indexed citations
5.
Zandvoort, André, Ymke M. van der Geld, Marnix R. Jonker, et al.. (2006). High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function. European Respiratory Journal. 28(1). 113–122. 27 indexed citations
6.
Geld, Ymke M. van der, et al.. (2005). Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils. Kidney International. 68(2). 537–541. 29 indexed citations
7.
Noordhoek, Jacobien A., Dirkje S. Postma, Lorian Menkema, et al.. (2005). Different Modulation of Decorin Production by Lung Fibroblasts from Patients with Mild and Severe Emphysema. COPD Journal of Chronic Obstructive Pulmonary Disease. 2(1). 17–25. 52 indexed citations
8.
Huitema, Minke G., Ymke M. van der Geld, Heike Berthold, et al.. (2003). Recombinant Protein to Analyze Autoantibodies to Proteinase 3 in Systemic Vasculitis. American Journal of Clinical Pathology. 120(4). 586–595. 5 indexed citations
9.
Geld, Ymke M. van der, et al.. (2003). Diversity of PR3-ANCA Epitope Specificity in Wegener's Granulomatosis. Analysis Using the Biosensor Technology. Journal of Clinical Immunology. 23(6). 460–468. 19 indexed citations
10.
Geld, Ymke M. van der, et al.. (2002). Role of proteoglycans in development and pathogenesis of emphysema.: Proteoglycans in Lung Disease. Data Archiving and Networked Services (DANS). 241–267. 5 indexed citations
11.
Geld, Ymke M. van der, Anton T. J. Tool, John J. Videler, et al.. (2002). Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis. Clinical & Experimental Immunology. 129(3). 562–570. 31 indexed citations
12.
Geld, Ymke M. van der, Ruurd van der Zee, Jan Willem Cohen Tervaert, et al.. (2001). Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: Epitope analysis using synthetic peptides. Kidney International. 59(1). 147–159. 35 indexed citations
13.
Geld, Ymke M. van der. (2000). Epitope mapping of anti-proteinase 3 antibodies, implication for Wegener's granulomatosis. 1 indexed citations
14.
Geld, Ymke M. van der, Minke G. Huitema, Casper Franssen, et al.. (2000). In vitroT lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG). Clinical & Experimental Immunology. 122(3). 504–513. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026